切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2020, Vol. 06 ›› Issue (01) : 51 -54. doi: 10.3877/cma.j.issn.2095-9605.2020.01.011

所属专题: 文献

综述

脂肪因子Omentin-1在临床疾病中的作用进展
吴宇婷1, 李影2, 孙晓芳2,()   
  1. 1. 225001 扬州,扬州大学护理学院
    2. 江苏省苏北人民医院内分泌科
  • 收稿日期:2019-11-15 出版日期:2020-02-28
  • 通信作者: 孙晓芳
  • 基金资助:
    扬州市科技计划项目(YZ2015047); 江苏省苏北人民医院技术项目(Fcjs201730)

Progress of the role of fat factor Omentin-1 in clinical disease

Yuting Wu1, Ying Li2, Xiaofang Sun2()   

  • Received:2019-11-15 Published:2020-02-28
  • Corresponding author: Xiaofang Sun
引用本文:

吴宇婷, 李影, 孙晓芳. 脂肪因子Omentin-1在临床疾病中的作用进展[J]. 中华肥胖与代谢病电子杂志, 2020, 06(01): 51-54.

Yuting Wu, Ying Li, Xiaofang Sun. Progress of the role of fat factor Omentin-1 in clinical disease[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2020, 06(01): 51-54.

[1]
De CM, Yang RZ, Lee MJ, et al. Omentin plasma levels and gene expression are decreased in obesity[J]. Diabetes, 2007, 56(6): 1655-1661.
[2]
Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance[J]. Physiological Reviews, 2007, 87(2): 507-520.
[3]
Mauer J, Chaurasia B, Goldau J, et a1. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin[J]. Nature Immunology, 2014, 15(5): 423-430.
[4]
Bhakta HK, Paudel P, Fujii H, et a1. Oligonol promotes glucose uptake by modulating the insulin signaling pathway in insulin-resistant HepG2 cells via inhibiting protein tyrosine phosphatase 1B[J]. Arch Pharm Res, 2017, 40(11): 1314-1327.
[5]
Chen T, Xing J, Liu Y. Effects of telmisartan on vascular endothelial function,inflammation and insulin resistance in patients with coronary heart disease and diabetes mellitus[J]. Experimental and Therapeutic Medicine, 2018, 15(1): 909-913.
[6]
Lu H, Bogdanovic E, Yu Z, et al. Combined Hyperglycemia and Hyperinsulinemia-Induced Insulin Resistance in Adipocytes Is Associated With Dual Signaling Defects Mediated by PKC-ζ[J]. Endocrinology, 2018, 159(4): 1658-1677.
[7]
郭莹族,谭丽艳,王一舒. 新诊断2型糖尿病患者血清CTRP 3与Omentin-1的水平变化与肥胖相关性胰岛素抵抗的关系[J]. 湖北民族学院学报(医学版), 2018, 35(4): 10-13.
[8]
Akbarzadeh S, Ghasemi S, Kalantarhormozi M, et al. Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI[J].Gynecol Endocrinol, 2012, 28(7): 521-524.
[9]
王楠楠,赵晓娟,陈薇, 等. 大鼠血清网膜素-1水平与胰岛素抵抗的相关性[J].中国病理生理杂志, 2014, (12): 2276-2279.
[10]
Elsaid NH, Sadik NA, Ahmed NR, et al.Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters[J]. Journal of clinical and translational endocrinology, 2018, 13: 14-19.
[11]
Alizadeh M, Asad MR, Faramarzi M, et al. Effect of Eight-Week High Intensity Interval Training on Omentin-1 Gene Expression and Insulin-Resistance in Diabetic Male Rats[J]. Annals of applied sport science, 2017, 5(2): 29-36.
[12]
Kawada T. Circulating omentin level, obesity and cancer risk[J]. Cytokine, 2020, 130: 155083.
[13]
Nurten E, Vogel M, Michael Kapellen T, et al. Omentin-1 and NAMPT serum concentrations are higher and CK-18 levels are lower in children and adolescents with type 1 diabetes when compared to healthy age, sex and BMI matched controls[J]. J Pediatr Endocrinol Metab, 2018, 31: 959-69.
[14]
Senay Zengi, Oguzhan Zengi, Aysegul Kirankaya, et al. Serum omentin-1 levels in obese children[J]. J Pediatr Endocrinol Metab, 2019, 32(3): 247-251.
[15]
Rothermel J, Lass N, Barth A, et al. Link between omentin-1, obesity and insulin resistance in children: Findings from a longitudinal intervention study[J]. Pediatr Obes. 2020, 15(5): e12605.
[16]
Yamawaki H, Tsubaki N, Mukohda M, et al. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels[J]. Biochemical and Biophysical Research Communications, 2010, 393(4): 668-672.
[17]
Tan YL, Ou HX, Zhang M, et al. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway[J]. Current pharmaceutical biotechnology, 2019, 20(5): 422-432.
[18]
Shang FJ, Wang JP, Liu XT, et al. Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome[J]. Biomarkers, 2011, 16(8): 657-662.
[19]
Zhong X, Zhang H, Tan H, et al. Association of serum omentin-1 levels with coronary artery disease[J]. Acta Pharmacologica Sinica, 2011, 32(7): 873-878.
[20]
Chen L, Wei B, Xu L, et al. The association of inflammatory markers and periodontal indexes with the risk of coronary heart disease in Chinese patients with type 2 diabetes mellitus[J]. Diabetes Res Clin Pract, 2018, 135: 37-44.
[21]
戎成振,王洪巨,卢家忠. 血浆网膜素-1水平和冠状动脉侧支循环的关系[J]. 蚌埠医学院学报, 2019, 44(5): 590-592.
[22]
Guariguata L, Linnenkamp U, Beagley J, et al. Global estimates of the prevalence of hyperglycaemia in pregnancy[J]. Diabetes Res Clin Pract, 2014, 103(2): 176-185.
[23]
Li J, Song C, Li C, et al. Increased risk of cardiovascular disease in women with prior gestational diabetes: a systematic review and meta analysis[J]. Diabetes Res Clin Pract, 2018, 140: 324-338.
[24]
Plows JF, Stanley JL, Baker PN, et al. The Pathophysiology of Gestational Diabetes Mellitus[J]. International Journal of Molecular Sciences, 2018, 19(11): 3342.
[25]
Fasshauer M, Bluher M, Stumvoll M. Adipokines in gestational diabetes [J]. Lancet Diabetes Endocrinol, 2014, 2(6): 488-99.
[26]
李晓红,潘宝龙,马润玫. 脂肪因子Omentin-1与妊娠期糖尿病相关性研究[J]. 国际检验医学杂志, 2017, 38(3): 291-294.
[27]
Mierzyński R, Dluski D, Nowakowski Ł, et al. Adiponectin and Omentin Levels as Predictive Biomarkers of Preterm Birth in Patients with Gestational Diabetes Mellitus[J]. BioMed Research International, 2018, 2018: 7154216.
[28]
Franz M, Polterauer M, Springer S, et al. Maternal and neonatal omentin-1 levels in gestational diabetes[J]. Archives of Gynecology and Obstetrics, 2018, 297(4): 885-889.
[29]
刘玥明,杨震,苏青. 抗炎因子与2型糖尿病[J].中华内分泌代谢杂志, 2015, 31(4): 375-378.
[30]
Rao SS, Hu Y, Xie PL, et al. Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines[J]. Bone Research, 2018, 6: 9.
[31]
Yamawaki H, Kuramoto J, Kameshima S, et al. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells[J]. Biochemical and Biophysical Research Communications, 2011, 408(2): 339-343.
[32]
Zhong X, Li X, Liu F, et al. Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway[J]. Biochemical and Biophysical Research Communications, 2012, 425(2): 401-406.
[33]
Tan YL, Zheng XL, Tang CK. The protective functions of omentin in cardiovascular diseases[J]. Clinica Chimica Acta, 2015, 448: 98-106.
[34]
Qi D, Tang X, He J, et al. Omentin protects against LPS-induced ARDS through suppressing pulmonary inflammation and promoting endothelial barrier via an Akt/eNOS-dependent mechanism[J]. Cell Death & Disease, 2016, 7(9): e2360.
[35]
Xu L, Zhu G, Wang L, et al. Synovial Fluid Omentin-1 Levels Are Inversely Correlated With Radiographic Severity of Knee Osteoarthritis[J]. Journal of Investigative Medicine, 2012, 60(3), 583-586.
[36]
Sit M, Aktas G, Yilmaz EE, et al. Serum omentin levels predicts mesenteric ischemia[J]. Bratisl Lek Listy, 2015, 116(3):173-6.
[1] 郭庆, 李冠琳, 刘慧, 魏炜, 于洋, 张纯. 脂肪间充质干细胞治疗糖尿病及其慢性并发症的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(01): 58-62.
[2] 刘琴, 袁蕾. lncRNA GAS5对胰岛素抵抗模型中卵巢颗粒细胞功能的影响及相关机制研究[J]. 中华细胞与干细胞杂志(电子版), 2021, 11(03): 137-145.
[3] 朱国英, 陈利, 丁永年, 杨长青, 朱风尚. 重视脂肪胰的基础和临床研究[J]. 中华消化病与影像杂志(电子版), 2022, 12(03): 129-132.
[4] 孙琳, 韩萍萍, 张碧琳, 张军霞. 血清WISP1水平与2型糖尿病患者血尿酸升高的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(02): 178-182.
[5] 靳潇潇, 郑聪, 何文强. 肾结石与高血压关系的研究进展[J]. 中华临床医师杂志(电子版), 2022, 16(12): 1284-1288.
[6] 王研, 丁旭, 黄艳红. 维生素D对多囊卵巢综合征患者生育影响的研究进展[J]. 中华临床医师杂志(电子版), 2021, 15(05): 393-396.
[7] 朱建琴, 李国青, 缪逸. 正常体质量人群简单胰岛素抵抗指数与高尿酸血症的相关性研究[J]. 中华临床医师杂志(电子版), 2020, 14(10): 808-812.
[8] 王嘉琳, 宋青. 妊娠合并胰岛素抵抗诊治的研究进展[J]. 中华产科急救电子杂志, 2024, 13(01): 29-32.
[9] 崔磊, 徐东升. 减重手术治疗肥胖患者胰岛素抵抗的研究进展[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 127-132.
[10] 张金娜, 盖家宁, 李影. 脂质运载蛋白2在肥胖症及相关疾病中的作用研究进展[J]. 中华肥胖与代谢病电子杂志, 2023, 09(01): 50-54.
[11] 于莉莉, 李艳花, 张朝阳, 邓一鸣, 林剑泷, 冯志伟. 不同组织慢性炎症的特点及其在胰岛素抵抗发展中的作用[J]. 中华肥胖与代谢病电子杂志, 2021, 07(04): 260-265.
[12] 吴勇, 林伟平, 李斯毅, 杨立文, 刘滢. 糖尿病肾病患者血清白脂素水平与肾功能和糖代谢指标的相关性研究[J]. 中华肥胖与代谢病电子杂志, 2021, 07(02): 104-107.
[13] 黄炎驱, 林延明, 余丹红. 不同通量血液透析联合血液透析滤过对胰岛素抵抗尿毒症患者的疗效比较[J]. 中华肥胖与代谢病电子杂志, 2021, 07(01): 36-40.
[14] 许庆玲, 张淑欣, 吴楚姗, 郑荣秀. 肥胖儿童黑棘皮病严重程度与胰岛素抵抗的相关性研究[J]. 中华肥胖与代谢病电子杂志, 2021, 07(01): 30-35.
[15] 梁俏丽, 陈静娟, 周锋, 邵燕, 王玉凯, 章成国. 胰岛素抵抗与缺血性脑卒中关系的研究进展[J]. 中华脑血管病杂志(电子版), 2022, 16(02): 120-124.
阅读次数
全文


摘要